As of April 19, 2025, Humacyte (HUMA) has a market cap of $0.26 billion USD. According to our data, Humacyte is ranked No.6691 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 19, 2025 | $0.26 B |
-59.89%
|
Dec 31, 2024 | $0.65 B |
77.82%
|
Dec 29, 2023 | $0.37 B |
34.60%
|
Dec 30, 2022 | $0.27 B |
-70.90%
|
Dec 31, 2021 | $0.93 B |
-28.71%
|
Dec 31, 2020 | $1.31 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Organovo
ONVO
|
$3.10 M |
0.000 M
|
![]() USA
|
![]() Vericel
VCEL
|
$2.07 B |
-0.000 M
|
![]() USA
|
![]() MiMedx Group
MDXG
|
$0.98 B |
0.000 M
|
![]() USA
|
![]() Axogen
AXGN
|
$0.69 B |
0.000 M
|
![]() USA
|
![]() TELA Bio
TELA
|
$37.82 M |
0.008 M
|
![]() USA
|
![]() Avita Medical
RCEL
|
$0.24 B |
0.000 M
|
![]() USA
|
![]() Repligen
RGEN
|
$7.30 B |
0.000 M
|
![]() USA
|
![]() Integra LifeSciences
IART
|
$1.22 B |
-0.000 M
|
![]() USA
|
![]() Mesoblast
MESO
|
$1.36 B |
0.000 M
|
![]() Australia
|
![]() Biolife Solutions
BLFS
|
$1.04 B |
-0.000 M
|
![]() USA
|
Market Cap | = | HUMA Stock Price | * | HUMA Shares Outstanding |
= | $1.68 | * | 0.16 B | |
= | $0.26 B |